CIK 0000872589
- Large accelerated filer
REGENERON PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- REGN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NY
- Entity type
- Operating
- EIN
- 133444607
- Phone
- +1 914-847-7000
- Business address
- 777 OLD SAW MILL RIVER ROAD, TARRYTOWN, NY, 10591
- Former names
- REGENERON PHARMACEUTICALS INC
- 4 Open-market sale EVP Research sold 3,540 shares at an average $629.34 ($2,227,851)
- 4 Open-market sale Director sold 100 shares at an average $607.14 ($60,714)
- 4 Open-market sale EVP Commercial sold 1,000 shares at $607.46 ($607,460)
- 4 Grant or award Director acquired 191 shares (grant or award)
- 4 Open-market sale EVP Commercial sold 1,000 shares at $625.00 ($625,000)
- 4 Grant or award Director acquired 191 shares (grant or award)
- 4 Grant or award Director acquired 191 shares (grant or award)
- 4 Grant or award Director acquired 191 shares (grant or award)
- 4 Grant or award Director acquired 191 shares (grant or award)
- 4 Open-market sale Director sold 100 shares at an average $624.95 ($62,495)
- 4 Grant or award Director acquired 191 shares (grant or award)
- 4 Grant or award Director acquired 191 shares (grant or award)
- 4 Grant or award Director acquired 191 shares (grant or award)
- 4 Shares withheld for taxes President and Chief Scientific gave up 310,097 shares (to pay taxes)
- 4 Other disposition Director disposed of 126 shares (code I)
- 4 Shares withheld for taxes SVP Controller gave up 270 shares (to pay taxes)
- 4 Shares withheld for taxes EVP Research gave up 697 shares (to pay taxes)
- 4 Shares withheld for taxes EVP Research and Development gave up 753 shares (to pay taxes)
- 4 Shares withheld for taxes EVP General Counsel and Secret gave up 697 shares (to pay taxes)
- 4 Open-market sale EVP Commercial sold 344 shares at $653.12 ($224,673)
Page 18 of 77 · 1,533 filings